Results

Total Results: 1,544 records

Showing results for "drug".

401. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioids-chronic-pain-surveillance-report-1-final.pdf
     April 01, 2022 - Drug Overdose/ 25. or/17-24 26. risk$.ti,ab,kf. A-4 27. … Drug Overdose/ 27. or/17-26 28. Substance Abuse Detection/ 29. … Drug Overdose/ 25. or/17-24 26. risk$.ti,ab,kf. 27. … Drug Overdose/ 27. or/17-26 28. Substance Abuse Detection/ 29. … Measures of diagnostic accuracy • Intermediate outcomes (e.g., pharmacokinetics/pharmacodynamics, drug-drug

402. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - Food and Drug Administration (FDA) fast-track status, and off-label investigations of zonisamide and … Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER); 2014 Apr 3. … Food and Drug Administration (FDA); 2014 Apr 03 [accessed 2014 May 27]. [3 p]. … Mobile medical applications: guidance for industry and Food and Drug Administration staff. … Food and Drug Administration (FDA); 2015 Feb 9. 44 p.

403. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug … birthweight infants to increase weight gain); interventions intended to target both the woman and fetus (a drug

404. Treatments for Fecal Incontinence: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_clinician.pdf
     July 01, 2016 - Food and Drug Administration (FDA) approved a vaginal bowel-control device in February 2015. … Food and Drug Administration; FI = fecal incontinence; FICA = Fecal Incontinence and Continence Assessment … Food and Drug Administration; FI = fecal incontinence; PFMT-BF = pelvic floor muscle training with biofeedback

405. Ch 11-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_11-user-guide-to-ocer_130129.pdf
     January 03, 2012 - adults are inherently more likely to be subject to polypharmacy and thus have a much higher risk of drug-drug … Pharmacoepidemiol Drug Saf. 2006;15(5): 291-303. 2. McCandless LC, Gustafson P, Levy A. … Pharmacoepidemiol Drug Saf. 2010;19:858-68. 6. … Pharmacoepidemiol Drug Saf. 2010;19(6):537-54. 17. Ionescu-Ittu R, Delaney JA, Abrahamowicz M. … Pharmacoepidemiol Drug Saf. 2009 Jul;18(7):562-71. 18.

406. Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
     March 01, 2012 - different classes of drug? … different classes of drug? … different classes of drug?. … therapy across the different classes of drug? … different classes of drug?

407. Hypertension-Pulmonary-Arterial Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
     April 01, 2013 - endoglin (with or without hereditary hemorrhagic telangiectasia) 1.2.3 Unknown 1.3 Drug … the poor prognosis and diminished quality of life associated with PAH—reinforces the need for new drug … Food and Drug Administration for PAH are: (1) inhaled treprostinil, a new delivery system for this … Additionally, combination drug therapy (using multiple drugs with different mechanisms of action) is … or continued therapy with that drug plus the addition of a second drug.

408. Atrial-Fibrillation-Ablation Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
     May 16, 2013 - The Food and Drug Administration (FDA), Health Canada, and Medicines and Healthcare Products Regulatory … would produce prima facie evidence that a conclusion was out of date, such as the withdrawal of a drug … controlled trial; AF=atrial fibrillation; RFA=radiofrequency catheter ablation; AAD=anti-arrhythmic drug … Comparison  of  antiarrhythmic  drug   therapy  and  radiofrequency  catheter   ablation … Cycle 2 Bittner 201113 RCT 80 pts with drug- refractory AF (PAF 55% and persistent AF 45%); mean

409. Ch 2-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_2-user-guide-to-ocer_130129.pdf
     January 01, 2011 - Paradoxical relations of drug treatment with mortality in older persons. … A meta-analysis of the association between adherence to drug therapy and mortality. … Practical issues in measuring cessation and re-initiation of drug use in databases. … [abstract] Pharmacoepidemiol Drug Saf. 2008;17 (suppl 1):S27. 35. Moride Y, Abenhaim L. … Pharmacoepidemiol Drug Saf. 2011;20 (supl 1):S250. 38. Suissa S.

410. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
     March 10, 2010 - Revised: The United States Food and Drug Administration defines SAE as any untoward medical occurrence … synthesis; and closer (but meeting our prior definition of lower or higher statin dose) to the same drug … But when we actually see that there is no common drug effect because there is substantial between study … In other words, the assumption of a common drug effect was wrong. … surogate outcomes with evidence and the outcomes without evidence for any one questions across all drug

411. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Food and Drug Administration (FDA); 2009 May 04 [accessed 2013 May 07]. [2 p]. … Food and Drug Administration (FDA); 2010 Aug 06 [accessed 2011 Mar 28]. [2 p]. … Food and Drug Administration (FDA). … Food and Drug Administration (FDA); 2012 Apr 01 [accessed 2013 Jun 19]. [2 p]. … Food and Drug Administration (FDA).

412. Microsoft Word - Comp Eff 10.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
     January 01, 2007 - We excluded comparisons of an ACEI + drug X versus an ARB + drug Y (e.g., enalapril + manidipine vs. … Drug Class Review on Angiotensin Converting Enzyme Inhibitors. Final Report. June 2005. … Drug Class Review on Angiotensin II Receptor Antagonists. Final Report. February 2006. … Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study … Pharmacoepidemiology & Drug Safety 2005;14(11):795-803. 77.

413. VU EPC DBD Protocol_AHRQ comments_revised_clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_research-protocol.pdf
     January 30, 2014 - safety of these drugs.65 The authors of a systematic review of antipsychotic and psychostimulant drug … We included terms to describe drug classes and individual agents. … Food and Drug Administration’s regulatory documents. … The drug classes considered are: alpha-agonists, anticonvulsants, second-generation (i.e., atypical) … List of pharmacologic agents for SIP Drug Company Anticonvulsants Carbamazepine (Tegretol®) Novartis

414. Disposition of Comments for CER 178 Newer Medications for Lower Urinary Tract Symptoms (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/prostatic-hyperplasia-medications_disposition-comments.pdf
     May 26, 2016 - summaries to the Results section providing baseline characteristics for enrolled populations for each drug … We revised the sentence to clarify: “Recently, newer drugs and drug in other classes approved for … It should be stated that these discontinuation rates are similar amongst the entire drug class. … Associated with the drug.102 Of the 91 patients prescribed silodosin, 42 percent considered, 95 percent … The report is a testament of the need for long-term data to better evaluate adherence, drug-related

415. Slide 1 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/marketing_evidence_evans.ppt
     September 13, 2006 - drawn from the commercial sector to promote changes in diverse socially important behaviors such as drug … (Evans et al., in press) Additional evidence from public health: Hornik et al. (2003): ONDCP anti-drug … Web-based dissemination, pocket cards, PDA applications Publication of evidence base on gabapentin & drug … drawn from the commercial sector to promote changes in diverse socially important behaviors such as drug … choices (lifestyle) Additional evidence on public health brands: Hornik et al. (2003): ONDCP anti-drug

416. CER 225: Evidence Summary Interventions for Substance Use Disorders in Adolescents: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-225-substance-abuse-adolescents-evidence-summary%20225%20Substance%20Use%20Adolescents.pdf
     May 01, 2020 - .  Motivational interviewing decreases combined alcohol and other drug use.  Combined cognitive behavioral … therapy and motivational interviewing decrease illicit drug use.

417. Emergency Medical Service/911 Workforce Mental or Behaviorial Health Issues (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/ems-911-workforce-topic-development-brief.pdf
     February 01, 2022 - Drug and alcohol dependence. 2008 Apr 1;94(1-3):267-71. doi: 10.1016/j.drugalcdep.2007.11.001. … use disorder":ti,ab,kw OR "drug use disorders":ti,ab,kw OR "drug abuse":ti,ab,kw OR [mh “Substance-Related … use disorder" OR "drug use disorders" OR "drug abuse") OR AB (“substance abuse” OR "substance use" … OR "drug use disorder" OR "drug use disorders" OR "drug abuse") OR (mh “Substance-Related Disorders” … use disorder"[tiab] OR "drug use disorders"[tiab] OR "drug abuse"[tiab] OR “Substance-Related Disorders

418. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - Food and Drug Administration and by decisions of companies to stop importing the whipworms or making …  Key Expert Comments: Experts commenting on this drug believe that reductions in PN use could … Food and Drug Administration (FDA). … Food and Drug Administration (FDA). FDA approves Gattex to treat short bowel syndrome. … Food and Drug Administration (FDA); 2012 Dec 21 [accessed 2013 Jun 5]. [2 p].

419. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug … Food and Drug Administration (FDA) ruled recently that this intervention is not subject to FDA approval … acquired from a pharmacy; the university does not cover or subsidize cost of the drug.6 Teva Pharmaceutical … Food and Drug Administration stated it would not intervene to require regulation of the machine.7 On … Obama administration drops its appeal of Plan B ruling, will widen access to drug. [internet].

420. Comparative Effectiveness Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
     January 01, 2006 - Pharmacokinetics, Indications and Dosing of Included Drugs Drug and Trade Name (Trade names … mg/day in 3- 4 Renal impairment: initiate with lowest recommended dosage, monitor closely Drug … or within 7 days of stopping drug during 9 months since start of treatment; when not known if … patient was taking drug at the time of the event, only those events that had occurred within … Both trials favored etodolac over the comparator drug.